These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2186629

  • 1. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
    Richman DD.
    Am J Med; 1990 May 21; 88(5B):8S-10S. PubMed ID: 2186629
    [Abstract] [Full Text] [Related]

  • 2. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M, Kemp SD, Parry NR, Larder BA.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5653-6. PubMed ID: 7685907
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.
    Larder BA, Kohli A, Bloor S, Kemp SD, Harrigan PR, Schooley RT, Lange JM, Pennington KN, St Clair MH.
    J Virol; 1996 Sep 15; 70(9):5922-9. PubMed ID: 8709213
    [Abstract] [Full Text] [Related]

  • 4. AZT resistance in isolates of HIV.
    Richman DD.
    Immunodefic Rev; 1991 Sep 15; 2(4):315-8. PubMed ID: 2059436
    [Abstract] [Full Text] [Related]

  • 5. Zidovudine resistance of human immunodeficiency virus.
    Richman DD.
    Rev Infect Dis; 1990 Sep 15; 12 Suppl 5():S507-10; discussion S510-2. PubMed ID: 2201072
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
    Biesert L, Zimmermann F, Schröder B, Matthes E, Suhartono H, Dietrich U, Rübsamen-Waigmann H.
    Behring Inst Mitt; 1991 Jul 15; (89):74-80. PubMed ID: 1930105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
    Wondimu Z, Sönnerborg A, Ayehunie S, Britton S, Strannegård O.
    Antiviral Res; 1992 Oct 01; 19(4):353-9. PubMed ID: 1281393
    [Abstract] [Full Text] [Related]

  • 9. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
    Larder BA, Darby G, Richman DD.
    Science; 1989 Mar 31; 243(4899):1731-4. PubMed ID: 2467383
    [Abstract] [Full Text] [Related]

  • 10. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
    Di Stefano M, Sabri F, Leitner T, Svennerholm B, Hagberg L, Norkrans G, Chiodi F.
    J Clin Microbiol; 1995 Feb 31; 33(2):352-5. PubMed ID: 7536214
    [Abstract] [Full Text] [Related]

  • 11. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
    St Clair MH, Martin JL, Tudor-Williams G, Bach MC, Vavro CL, King DM, Kellam P, Kemp SD, Larder BA.
    Science; 1991 Sep 27; 253(5027):1557-9. PubMed ID: 1716788
    [Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA, Ripley D, Hsia K.
    Antimicrob Agents Chemother; 1989 Jun 27; 33(6):920-3. PubMed ID: 2548440
    [Abstract] [Full Text] [Related]

  • 13. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
    Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA.
    J Virol; 1992 Jan 27; 66(1):12-9. PubMed ID: 1727474
    [Abstract] [Full Text] [Related]

  • 14. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
    Sheehy N, Desselberger U.
    J Gen Virol; 1993 Feb 27; 74 ( Pt 2)():223-8. PubMed ID: 7679140
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG, MacInnes H, Bennett D, Weinstock H, Heneine W.
    J Virol; 2004 Jul 27; 78(14):7545-52. PubMed ID: 15220429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
    Vaccaro JA, Anderson KS.
    Biochemistry; 1998 Oct 06; 37(40):14189-94. PubMed ID: 9760256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.